• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在原发性预防 ICD 患者中,先前无症状非持续性室性心动过速对随后 ICD 干预和心力衰竭住院的临床意义。

Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients.

机构信息

Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstrasse 5, 40225, Düsseldorf, Germany.

CARID, Cardiovascular Research Institute Düsseldorf, Medical Faculty, Heinrich-Heine-University, Moorensstrasse 5, 40225, Düsseldorf, Germany.

出版信息

Eur J Med Res. 2020 Mar 17;25(1):5. doi: 10.1186/s40001-020-0401-x.

DOI:10.1186/s40001-020-0401-x
PMID:32183891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7076933/
Abstract

BACKGROUND

The prognostic implications of non-sustained ventricular tachycardia (NSVT) and their significance as therapeutic targets in patients without prior sustained ventricular arrhythmias remain undetermined. The aim of this study was to investigate the prognostic significance of asymptomatic NSVT in patients who had primary prevention implantable cardioverter-defibrillator (ICD) implantation due to ischemic or non-ischemic cardiomyopathy (ICM, NICM).

METHODS

We enrolled 157 consecutive primary prevention ICD patients without previous appropriate ICD therapy (AIT). Patients were allocated to two groups depending on the presence or absence of NSVT in a 6-month period prior to enrollment. The incidence of AIT and unplanned hospitalization due to decompensated heart failure (HF) were assessed during follow-up.

RESULTS

In 51 patients (32%), precedent NSVT was documented. During a median follow-up of 1011 days, AIT occurred in 36 patients (23%) and unplanned HF hospitalization was observed in 32 patients (20%). In precedent NSVT patients, the incidence of AIT and unplanned HF hospitalization was significantly higher as compared to patients without precedent NSVT (AIT: 29/51 [57%] vs. 7/106 [7%], P < 0.001, log-rank; HF hospitalization: 16/51 [31%] vs. 16/106 [15%], P = 0.043, log-rank). Cox-regression demonstrated that precedent NSVT independently predicted AIT (P < 0.0001). In subgroup analyses, precedent NSVT predicted AIT in both ICM and NICM (P < 0.0001, P = 0.020), but predicted HF hospitalization only in patients with ICM (P = 0.0030).

CONCLUSIONS

Precedent non-sustained VT in patients with primary prevention ICDs is associated with subsequent appropriate ICD therapies, and is an independent predictor of unplanned heart failure hospitalizations in patients with ischemic cardiomyopathy.

摘要

背景

非持续性室性心动过速(NSVT)的预后意义及其作为无持续性室性心律失常既往史患者的治疗靶点的意义尚不确定。本研究旨在探讨因缺血性或非缺血性心肌病(ICM、NICM)而接受原发性预防植入式心脏复律除颤器(ICD)植入的患者无症状性 NSVT 的预后意义。

方法

我们纳入了 157 例因缺血性或非缺血性心肌病(ICM、NICM)而接受原发性预防 ICD 植入且既往无适当 ICD 治疗(AIT)的连续患者。根据患者在入组前 6 个月内是否存在 NSVT,将患者分为两组。在随访期间评估 AIT 和因心力衰竭(HF)失代偿而计划外住院的发生率。

结果

在 51 例(32%)患者中记录到存在先前的 NSVT。在中位随访 1011 天期间,36 例(23%)患者发生 AIT,32 例(20%)患者因 HF 失代偿而计划外住院。与无先前 NSVT 的患者相比,先前 NSVT 患者的 AIT 和计划外 HF 住院发生率显著更高(AIT:51/51 [57%] vs. 106/106 [7%],P<0.001,对数秩检验;HF 住院:16/51 [31%] vs. 106/106 [15%],P=0.043,对数秩检验)。Cox 回归分析表明,先前的 NSVT 独立预测 AIT(P<0.0001)。亚组分析显示,先前的 NSVT 预测 ICM 和 NICM 患者的 AIT(P<0.0001,P=0.020),但仅预测 ICM 患者的 HF 住院(P=0.0030)。

结论

原发性预防 ICD 患者先前的非持续性 VT 与随后的适当 ICD 治疗相关,是缺血性心肌病患者计划外心力衰竭住院的独立预测因子。

相似文献

1
Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients.在原发性预防 ICD 患者中,先前无症状非持续性室性心动过速对随后 ICD 干预和心力衰竭住院的临床意义。
Eur J Med Res. 2020 Mar 17;25(1):5. doi: 10.1186/s40001-020-0401-x.
2
Clinical Impact of Circulating Galectin-3 on Ventricular Arrhythmias and Heart Failure Hospitalization Independent of Prior Ventricular Arrhythmic Events in Patients with Implantable Cardioverter-defibrillators.循环半乳糖凝集素-3 对植入式心脏复律除颤器患者室性心律失常和心力衰竭住院的临床影响,与先前的室性心律失常事件无关。
Intern Med. 2022;61(7):969-977. doi: 10.2169/internalmedicine.7886-21. Epub 2022 Apr 1.
3
Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy.一级预防性植入式心脏转复除颤器治疗后的长期预后和预后因素。
J Cardiol. 2024 Sep;84(3):170-176. doi: 10.1016/j.jjcc.2024.02.006. Epub 2024 Feb 20.
4
Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy.缺血性和非缺血性心肌病一级预防患者中合适的植入式心脏复律除颤器(ICD)治疗的预测因素。
Pacing Clin Electrophysiol. 2010 Mar;33(3):320-9. doi: 10.1111/j.1540-8159.2009.02566.x. Epub 2009 Oct 1.
5
Non-Sustained Ventricular Tachycardia Episodes Predict Future Hospitalization in ICD Recipients with Heart Failure.非持续性室性心动过速发作可预测心力衰竭植入式心脏复律除颤器患者未来的住院情况。
Arq Bras Cardiol. 2017 Oct;109(4):284-289. doi: 10.5935/abc.20170141.
6
Prognostic Significance of Nonsustained Ventricular Tachycardia Episodes Occurring Early After Implantable Cardioverter-Defibrillator Implantation Among Patients With Left Ventricular Dysfunction.植入式心脏复律除颤器植入后早期发生的非持续性室性心动过速发作在左心室功能不全患者中的预后意义
Am J Cardiol. 2016 Nov 15;118(10):1503-1510. doi: 10.1016/j.amjcard.2016.08.015. Epub 2016 Aug 23.
7
Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.仅采用植入式心脏复律除颤器预防治疗的缺血性和非缺血性心力衰竭患者的生存和心律失常风险:倾向评分匹配分析。
Int J Cardiol. 2019 Jan 1;274:163-169. doi: 10.1016/j.ijcard.2018.09.003. Epub 2018 Sep 5.
8
Predictive value of rapid-rate non-sustained ventricular tachycardia in the occurrence of appropriate implantable cardioverter-defibrillator therapy.快速性非持续性室性心动过速对植入式心脏复律除颤器治疗的预测价值。
J Interv Card Electrophysiol. 2020 Apr;57(3):473-480. doi: 10.1007/s10840-019-00557-4. Epub 2019 May 9.
9
Prognostic implications of nonsustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathy.肥厚型心肌病高危患者非持续室性心动过速形态的预后意义。
J Cardiovasc Electrophysiol. 2020 Aug;31(8):2093-2098. doi: 10.1111/jce.14571. Epub 2020 Jun 9.
10
Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.植入式心脏复律除颤器记录的非持续性室性心动过速对肥厚型心肌病患者的临床影响。
J Cardiovasc Electrophysiol. 2014 Nov;25(11):1180-7. doi: 10.1111/jce.12492. Epub 2014 Aug 27.

引用本文的文献

1
JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias.《日本循环学会/日本心律学会2024年心律失常管理指南重点更新》
J Arrhythm. 2025 Jun 16;41(3):e70033. doi: 10.1002/joa3.70033. eCollection 2025 Jun.
2
SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices.钠-葡萄糖协同转运蛋白2抑制剂(SGLT2i)可减少植入心脏电子装置的心力衰竭患者的心律失常事件。
ESC Heart Fail. 2025 Jun;12(3):2125-2133. doi: 10.1002/ehf2.15223. Epub 2025 Feb 7.
3
Characteristics Associated with Ventricular Tachyarrhythmias and Their Prognostic Impact in Heart Failure with Mildly Reduced Ejection Fraction.

本文引用的文献

1
Predictive value of rapid-rate non-sustained ventricular tachycardia in the occurrence of appropriate implantable cardioverter-defibrillator therapy.快速性非持续性室性心动过速对植入式心脏复律除颤器治疗的预测价值。
J Interv Card Electrophysiol. 2020 Apr;57(3):473-480. doi: 10.1007/s10840-019-00557-4. Epub 2019 May 9.
2
Avoiding inappropriate therapy of single-lead implantable cardioverter-defibrillator by using atrial-sensing electrodes.避免使用心房感知电极对单导联植入式心脏除颤器进行不当治疗。
J Cardiovasc Electrophysiol. 2018 Dec;29(12):1682-1689. doi: 10.1111/jce.13736. Epub 2018 Oct 5.
3
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
轻度射血分数降低的心力衰竭患者室性快速心律失常的相关特征及其预后影响
J Clin Med. 2024 May 1;13(9):2665. doi: 10.3390/jcm13092665.
4
Cyclical endometrial repair and regeneration: Molecular mechanisms, diseases, and therapeutic interventions.周期性子宫内膜修复与再生:分子机制、疾病及治疗干预措施
MedComm (2020). 2023 Dec 1;4(6):e425. doi: 10.1002/mco2.425. eCollection 2023 Dec.
5
Clinical Impact of Circulating Galectin-3 on Ventricular Arrhythmias and Heart Failure Hospitalization Independent of Prior Ventricular Arrhythmic Events in Patients with Implantable Cardioverter-defibrillators.循环半乳糖凝集素-3 对植入式心脏复律除颤器患者室性心律失常和心力衰竭住院的临床影响,与先前的室性心律失常事件无关。
Intern Med. 2022;61(7):969-977. doi: 10.2169/internalmedicine.7886-21. Epub 2022 Apr 1.
6
Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies.ICD 患者中非持续室性心动过速的周期长度:对后续适当治疗的影响。
BMC Cardiovasc Disord. 2021 May 31;21(1):268. doi: 10.1186/s12872-021-02087-2.
2017年美国心脏协会/美国心脏病学会/心律学会室性心律失常患者管理和心脏性猝死预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
Circulation. 2018 Sep 25;138(13):e272-e391. doi: 10.1161/CIR.0000000000000549.
4
Declining Risk of Sudden Death in Heart Failure.心力衰竭患者猝死风险降低。
N Engl J Med. 2017 Jul 6;377(1):41-51. doi: 10.1056/NEJMoa1609758.
5
Prognostic Significance of Nonsustained Ventricular Tachycardia Episodes Occurring Early After Implantable Cardioverter-Defibrillator Implantation Among Patients With Left Ventricular Dysfunction.植入式心脏复律除颤器植入后早期发生的非持续性室性心动过速发作在左心室功能不全患者中的预后意义
Am J Cardiol. 2016 Nov 15;118(10):1503-1510. doi: 10.1016/j.amjcard.2016.08.015. Epub 2016 Aug 23.
6
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).2015年欧洲心脏病学会(ESC)室性心律失常患者管理和心脏性猝死预防指南:欧洲心脏病学会(ESC)室性心律失常患者管理和心脏性猝死预防特别工作组。认可机构:欧洲儿科和先天性心脏病协会(AEPC)。
Eur Heart J. 2015 Nov 1;36(41):2793-2867. doi: 10.1093/eurheartj/ehv316. Epub 2015 Aug 29.
7
The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT.非持续性室性心动过速对MADIT-CRT试验中逆向重构、心力衰竭及已治疗室性心律失常的影响
J Cardiovasc Electrophysiol. 2014 Oct;25(10):1082-7. doi: 10.1111/jce.12456. Epub 2014 Jun 24.
8
Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.MADIT-CRT 研究中心心肌底物、植入式心脏复律除颤器电击与死亡率之间的关系。
Eur Heart J. 2014 Jan;35(2):106-15. doi: 10.1093/eurheartj/eht451. Epub 2013 Oct 31.
9
Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).植入式心脏复律除颤器检测时发现快速性非持续性室性心动过速:与 SCD-HeFT(心力衰竭中的猝死试验)结局的关系。
J Am Coll Cardiol. 2013 May 28;61(21):2161-8. doi: 10.1016/j.jacc.2013.02.046. Epub 2013 Mar 26.
10
Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.冠心病患者植入除颤器前稳定型室性心动过速的导管消融(VTACH):一项多中心随机对照试验。
Lancet. 2010 Jan 2;375(9708):31-40. doi: 10.1016/S0140-6736(09)61755-4.